NewGenIvf Group Limited Class A Ordinary Shares

NewGenIvf Group Limited Class A Ordinary Shares

NIVF · NASDAQ · Healthcare / Medical Care Facilities

0.2312USD-0.05 (-16.44%)

Price History

Full chart

Market Stats

Previous Close0.2767
Open0.2118
Day Range0.189 – 0.2435
52-Week Range0.3196 – 1,539.00
Volume16.28M
Market Cap833.53K
P/E (TTM)0.00
Forward P/E0.01
EPS200.83
Dividend Yield0.00%
Beta-0.04
50-Day Avg1.67
200-Day Avg22.75

About

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Wing Fung Siu
  • Employees87
  • HeadquartersPS Tower,36/39-36/40, Bangkok, Thailand, 10110, USA
  • Websitehttps://www.nivf.global

Leadership

  • Mr. Wing Fung SiuCo-Founder, Chairman & CEO · b. 1956
  • Ms. Hei Yue FongCo-Founder, Chief Marketing Officer & Director · b. 1982
  • Mr. Ho Fai ChungChief Financial Officer · b. 1964

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.12M5.94M5.14M5.43M4.73M
Growth (%)-+44.35%-13.59%+5.78%-13.01%
Cost of Revenue3.09M4.41M3.45M3.61M3.77M
Gross Profit1.02M1.54M1.68M1.83M955.85K
Gross Margin24.89%25.87%32.74%33.63%20.22%
Operating Expense826.24K1.14M4.20M2.99M11.68M
Operating Income198.76K398.70K-2.52M-1.16M-10.73M
Operating Margin4.83%6.71%-49.10%-21.35%-226.95%
EBITDA587.01K725.69K-2.52M24.26K10.84M
EBITDA Margin14.25%12.21%-49.10%0.45%229.45%
Net Income-533458.67K-690.85K-525.00K9.88M
Net Income Margin-0.01%7.72%-13.45%-9.66%209.02%
Interest Expense88.29K77.76K46.18K778.66K616.42K
Interest Expense % of Total Revenue2.14%1.31%0.90%14.33%13.04%

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.41M2.90M21.32M3.58M32.72M
Total Liabilities2.33M2.80M5.72M5.06M6.74M
Total Equity-775.94K563.11K15.60M-1.05M26.63M
Cash28.76K27.56K42.22K457.74K758.62K
Total Debt925.97K452.04K1.62M3.03M4.86M
Net Debt897.20K424.49K1.58M2.57M4.11M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.43M-527.12K-857.36K-8.26M-10.93M
Investing Cash Flow-16.57K-69.69M--53.05K-7.56M
Financing Cash Flow-1.54M70.27M-50.41M8.68M18.99M
Capital Expenditure16.57K94.45K69.85K53.04K5.75M
Free Cash Flow1.42M-621.58K-927.20K-8.32M-16.68M
Dividends Paid00000
FCF to OCF98.84%117.92%108.15%100.64%152.62%
Dividend Paid to FCF0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateFeb 15, 2022Apr 15, 2022Aug 12, 2022Nov 9, 2022Mar 3, 2023May 11, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Dec 5, 2024Dec 31, 2024May 15, 2025Oct 10, 2025
EPS Estimate0.00----------0.000.00
EPS Actual0.00-0.02-16.410.020.080.012838.504217.09-46153.06-0.04-855.660.000.73
Surprise-------------
Timing-------------

Key Statistics & Ratios

Market Cap833.53K
Enterprise Value5.56M
Trailing P/E0.00
Forward P/E0.01
Price / Sales0.18
Price / Book0.05
EPS200.83
Book Value994.53
Revenue (TTM)4.73M
Gross Profit (TTM)955.85K
EBITDA-10.54M
Profit Margin209.03%
Operating Margin-349.13%
Return on Equity79.40%
Return on Assets-36.94%
Shares Outstanding2.40M
Shares Float30.42K
Beta-0.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.38%
Insiders
42.28%
Retail / Other
56.34%

Top Institutional Holders

  • Tower Research Capital LLC
    1.50K0.26%
  • UBS Group AG
    2000.04%
  • SBI Securities Co Ltd
    50.00%
  • Morgan Stanley - Brokerage Accounts
    10.00%

Stock Splits

  • Oct 23, 20261:8
  • Oct 12, 20261:4
  • Sep 1, 20261:3
  • Jul 6, 20261:3
  • Mar 16, 20261:4
  • Jan 26, 20261:3
  • Dec 1, 20251:5
  • Aug 4, 20251:5
  • May 5, 20251:10